Cystic hygroma is a condition that affects the lymphatic system, which is responsible for removing excess fluid from the body. This condition can cause swelling and pain in the neck, chest, and abdomen. It can also cause difficulty breathing, eating, and speaking. Though it is a rare condition, it is important to understand the causes and treatments for cystic hygroma in order to properly diagnose and treat it.
Cystic hygroma is a condition that affects the lymphatic system, which is responsible for removing excess fluid from the body. It is caused by a malformation of the lymphatic vessels, which causes them to become blocked and unable to function properly. This blockage causes a buildup of fluid in the affected area, resulting in swelling and pain. Cystic hygroma can affect any area of the body, but it is most commonly found in the neck, chest, and abdomen.
The most common symptom of cystic hygroma is swelling in the affected area. This swelling can cause pain, difficulty breathing, eating, and speaking. Other symptoms can include a feeling of fullness in the affected area, a lump or mass, and skin discoloration.
The exact cause of cystic hygroma is not known, but it is believed to be caused by a malformation of the lymphatic vessels. This malformation can be caused by a genetic mutation, an infection, or a trauma to the affected area. It is also possible for cystic hygroma to be caused by an underlying condition such as lymphoma or leukemia.
In order to diagnose cystic hygroma, a doctor will typically use imaging tests such as an ultrasound or MRI. These tests can help to identify the location and extent of the swelling. A biopsy may also be used to confirm the diagnosis.
The treatment for cystic hygroma depends on the severity of the condition and the underlying cause. In some cases, the condition may resolve on its own without treatment. However, if the condition does not improve or worsens, then treatment may be necessary.
In cases where the cystic hygroma is causing pain or difficulty breathing, eating, or speaking, surgery may be recommended. The goal of surgery is to remove the blockage in the lymphatic vessels and allow them to function properly. This can help to reduce the swelling and improve the symptoms.
In some cases, medication may be used to help reduce the swelling and improve the symptoms of cystic hygroma. These medications can include steroids, anti-inflammatory drugs, and antibiotics.
Radiation therapy can also be used to help reduce the swelling and improve the symptoms of cystic hygroma. This therapy uses high-energy X-rays to shrink the cyst and reduce the swelling.
Cystic hygroma is a condition that affects the lymphatic system and can cause swelling and pain in the neck, chest, and abdomen. The exact cause of the condition is not known, but it is believed to be caused by a malformation of the lymphatic vessels. Treatment for cystic hygroma depends on the severity of the condition and the underlying cause, but can include surgery, medication, and radiation therapy. It is important to understand the causes and treatments for cystic hygroma in order to properly diagnose and treat it.
1.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
In prostate cancer survivorship, sleep disturbances are underappreciated.
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
a cutting-edge cancer diagnostic tool.
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Community Survivorship Networks for Long-Term Cancer Wellness
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Integrated Insights in Hematology and Quality Improvement
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Hands-on Workshop: Hematology
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation